Skip to content
Pakistan Era logo
Guides

How to Check Your Cancer Medicine Against DRAP's 2026 Fake Medicine Alerts in Pakistan

Match your cancer medicine batch with DRAP 2026 alerts on Imfinzi, Enhertu, Jakavi, Darzalex and nine Karachi lab products, and see what to do if it matches.

Ali Akhtar, author at Pakistan EraAli AkhtarUpdated 6 min read
A plain wooden desk with a glass of water and a pen beside a window with soft daylight

If you or a family member takes a cancer medicine, find the batch number on the pack and compare it with the 15 products in DRAP's four 2026 oncology alerts below. If the name and batch both match, do not use the pack, keep it, and call your doctor the same day. DRAP, the Drug Regulatory Authority of Pakistan, issued Alert 27 (Imfinzi and Enhertu) on 6 May 2026, Alerts 37 (Darzalex) and 38 (Jakavi) on 16 July 2026, and Alert 39 (nine products from a Karachi lab) on 29 July 2026. Do not stop any medicine without asking your doctor.

Falsified cancer medicine is dangerous because a fake can look the same and do nothing. DRAP's alerts warn of therapeutic failure, disease progression and delay in life-saving treatment. Medicine stays in homes, clinics and shops for months after an alert, so these batches are still worth checking now.

Five steps to check a cancer medicine pack against DRAP alerts

Every named batch, matched to its product

The table below is copied from the four alert pages on dra.gov.pk, read again on 8 November 2026. Each batch number sits next to the exact product it belongs to, so you can match your pack in one look.

Alert and dateProduct as DRAP names itBatch numberDRAP finding
39, 29 July 2026Leukeran 2mg tablet512900Unregistered (ingredient confirmed)
39, 29 July 2026Sorafenib 200mg tablet (Soraclog)GST56925-CSpurious and unregistered (ingredient not identified)
39, 29 July 2026Arimidex 1mg tabletB2417Unregistered (ingredient confirmed)
39, 29 July 2026Lenvaxen 4 capsule26ALV04004Unregistered (ingredient confirmed)
39, 29 July 2026Cyclophosphamide 50mg tabletOT0470Spurious and unregistered (ingredient not identified)
39, 29 July 2026Gefimed 250mg tablet25GST016Unregistered (ingredient confirmed)
39, 29 July 2026Lenvatinib 10mg capsule (Lenvalieva)C25LN03B3Unregistered (ingredient confirmed)
39, 29 July 2026Lenalidomide 10mg capsuleOC0090Unregistered (ingredient confirmed)
39, 29 July 2026Nintedanib soft gelatin capsule (Nindanib 150)24250052Unregistered (ingredient confirmed)
38, 16 July 2026Jakavi (ruxolitinib) 20mg tabletsAVT50Falsified, ingredient absent in lab test
38, 16 July 2026Jakavi (ruxolitinib) 15mg tabletsFNR06, SGL04Falsified
37, 16 July 2026Darzalex (daratumumab) injection 400mg/20mLSTV1K01Falsified
37, 16 July 2026Darzalex (daratumumab) injection 100mg/5mLMYS7381Falsified
27, 6 May 2026Imfinzi (durvalumab) injection 500mg/10mlASCBFalsified, batch never made
27, 6 May 2026Enhertu 100mgDK1262Falsified, batch never made

What DRAP found in each alert

Alert 39 came from the Drug Testing Laboratory Sindh in Karachi. In two products, the sorafenib and the cyclophosphamide, the lab could not find the declared medicine at all, so DRAP calls them spurious. In the other seven the medicine was present, but the packs were not registered for sale in Pakistan. An unregistered pack has had no DRAP check of its quality, storage or source.

Alert 27 is the one closest to home. DRAP says doctors at hospitals in Lahore raised questions about the packs. The makers then confirmed that Imfinzi batch ASCB and Enhertu batch DK1262 were never produced. The Enhertu cartons had errors in labels, serial numbers, printing and barcodes.

Alerts 37 and 38 repeat World Health Organization alerts. Fake Darzalex was found in the Maldives and Mexico after supply through unauthorised distributors. Fake Jakavi was found in Iran, Turkey and Russia, mostly sold online. DRAP does not say these packs were found in Pakistan, but it lists them because the same routes can reach any country.

The DRAP cancer medicine alerts of 2026 and their dates

Check your pack in five steps

The batch number is printed on the box and on the strip, vial or bottle, usually near the manufacturing and expiry dates. It is marked "Batch", "Lot" or "B. No". It is not the price or the registration number.

  1. Find the medicine name, strength and batch number on the pack.
  2. Compare all three with the table above.
  3. If they match, do not use the pack. Keep it with the receipt and note where you bought it.
  4. Call your doctor or hospital pharmacy the same day and ask how to get a safe supply.
  5. Report it to DRAP through the "Report a Problem" link on dra.gov.pk, or call the DRAP helpline on 0800-03727 (Monday to Friday, 8 am to 4 pm).

Do not stop treatment on your own because of an alert. A missed dose can also be harmful. Your doctor must decide the next step.

Buy only from licensed pharmacies and hospital pharmacies

DRAP's advice in all four alerts is the same: buy medicines only from licensed pharmacies and other authorised outlets. Be careful with online sellers, social media offers, and anyone selling a "cheaper imported" pack outside a pharmacy. Seven of the nine products in Alert 39 were real medicine in unregistered packs, which is exactly what a grey import looks like.

Our guide to checking a pharmacy's drug licence in Punjab shows how to confirm a shop. To check whether a medicine is allowed for sale, use the guide to checking a medicine is registered with DRAP. For every 2026 alert on one page, see the full list of DRAP recall alerts for 2026.

Cancer and other long-term treatments also carry safety warnings that have nothing to do with fakes. Patients on azathioprine or mercaptopurine, which are used in leukaemia and in immune conditions, should read our guide on DRAP's warning on itching in pregnancy with azathioprine or mercaptopurine. If a relative also takes herbal tonics alongside treatment, check them with our guide on checking a herbal or Unani product is enlisted with DRAP.

For help with the cost of treatment, the guide to cancer treatment and financial support at Shaukat Khanum explains one route, and the report on free childhood cancer medicines covers children.

Report a bad pack or a side effect

DRAP asks health workers and the public to report problems to its pharmacovigilance centre, using its Adverse Event Reporting Form or the online link on each alert page. Report even if you are not sure. Write the name, batch, shop and date.

The steps are in our guide to reporting a medicine side effect to DRAP. If you believe a shop sells fakes, read the guide to reporting counterfeit medicine. This guide is not medical advice.

Common questions about fake cancer medicine alerts

Are these alerts still active?

Treat these alerts as active until DRAP withdraws them.

Was any fake cancer medicine found in Pakistan?

Yes. Alert 39 products were tested by the Sindh lab in Karachi, and Alert 27 began with questions from Lahore hospitals. Alerts 37 and 38 are based on finds abroad.

What if my pack matches a batch number?

Do not use it, keep it, and call your doctor the same day. Do not stop treatment without medical advice.

Has DRAP issued a newer cancer medicine alert?

Not as of 8 November 2026. The alerts after 39, up to Alert 51 of 5 November 2026, cover vaccines, antibiotics, syringes, eye sprays and other products, not cancer medicines.

Does an alert mean every pack of that medicine is fake?

No. DRAP names specific batches. A registered pack from a licensed pharmacy with a different batch number is not named in these alerts.

How we verified this

What we checked and where we read it.

Last checked 8 November 2026. The sources are the DRAP recall alerts listing and the alert pages for Alert 27, Alert 37, Alert 38 and Alert 39, plus the DRAP home page for the helpline.

About the author

Ali Akhtar, author at Pakistan Era

Tax, Bills and Technology Writer

Ali Akhtar

Ali Akhtar is a young and curious voice here at Pakistan Era. He is currently pursuing his A-Levels and has a growing interest in Pakistan’s changing industrial landscape and educational trends. Ali likes to write in a way that helps him explain and explore the world around him. His writing reflects the perspective of the new generation navigating the evolving trends of Pakistan where technology, youth innovation, and shifting opportunities are reshaping the country’s future.

TopicsDRAPCancerFake MedicinePharmacyHealth